Chaojun Yan
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Molecular Biology top 10%
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
-
- Mitochondrial Function and Pathology 8
- RNA modifications and cancer 5
- ATP Synthase and ATPases Research 5
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 4
- Co-authors
- Zhiyin Song (12 shared papers)Li Chen (4 shared papers)Bing Liu (2 shared papers)Ling Zeng (2 shared papers)Meng Xu (1 shared paper)Laurent Désaubry (1 shared paper)Hussein Abou‐Hamdan (1 shared paper)Ming-liang Tang (1 shared paper)
- Journals
- Autophagy (3 papers)eLife (2 papers)Frontiers in Oncology (1 paper)The EMBO Journal (1 paper)Nature Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Chaojun Yan
20 papers receiving 1.3k citations
Chaojun Yan's Hit Papers
Peers
Comparison fields: 5 of 85
- Clinical Biochemistry 120
- Molecular Biology 863
- Epidemiology 371
- Cancer Research 150
- Geriatrics and Gerontology 28
Countries citing papers authored by Chaojun Yan
This map shows the geographic impact of Chaojun Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaojun Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaojun Yan more than expected).
Fields of papers citing papers by Chaojun Yan
This network shows the impact of papers produced by Chaojun Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaojun Yan. The network helps show where Chaojun Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaojun Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis Hit paper breakdown → | 2019 | 338 |
| 2 | 2019 | 244 | |
| 3 | 2014 | 192 | |
| 4 | 2020 | 107 | |
| 5 | 2022 | 102 | |
| 6 | 2018 | 93 | |
| 7 | 2019 | 86 | |
| 8 | 2019 | 31 | |
| 9 | 2023 | 30 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2025 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2025 | 8 | |
| 15 | 2025 | 8 | |
| 16 | 2025 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 1 |
About Chaojun Yan
Chaojun Yan is a scholar working on Cancer Research, Molecular Biology, Clinical Biochemistry, Epidemiology and Energy Engineering and Power Technology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (8 papers), Autophagy in Disease and Therapy (6 papers), RNA modifications and cancer (5 papers), ATP Synthase and ATPases Research (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (4 papers), Metabolism and Genetic Disorders (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Clinical Biochemistry (120 citations), Molecular Biology (863 citations), Epidemiology (371 citations), Cancer Research (150 citations) and Geriatrics and Gerontology (28 citations). Chaojun Yan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhiyin Song, Li Chen, Bing Liu, Ling Zeng, Meng Xu, Laurent Désaubry, Hussein Abou‐Hamdan, Ming-liang Tang, Bin Lü and Shi Chen. Their work appears in journals such as Autophagy, eLife, Frontiers in Oncology, The EMBO Journal and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.